The latest call
FetchingAethlon Medical Inc. reported on November 12, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
Loading company
Aethlon Medical Inc.
AEMD · Nasdaq · ·
$5.32-3.4%Nov 13 close
Reported results on November 12, 2026; they are not in these figures yet.
Figures through June 30, 2026, from the 10-Q filed August 13, 2026
Past performance
- 1W
- -2.8%
- 1M
What Aethlon Medical Inc. reported on November 12, 2026
The quarter ending March 31, 2023, against the same quarter a year earlier.
| Measure | 3 months toMar 31, 2023 | 3 months toMar 31, 2022 | Change |
|---|---|---|---|
| Total Revenue | $574.2K | $13.1K | +4,278.20% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Earnings calls
How the share price reacted
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Close before
$5.59
Nov 11, 2026
Close after
$5.32
Nov 13, 2026
Move
-4.92%
0 shares traded, against a normal 49.87K
What Aethlon Medical Inc. does
Medical, Inc . Aethlon Medical, Inc. (Nasdaq: AEMD) is a clinical-stage medical therapeutic company headquartered in San Diego, California. The Company is advancing the Hemopurifier®, an investigational extracorporeal immunotherapeutic platform designed to remove tumor-derived extracellular vesicles and enveloped viruses from circulation for potential applications in oncology, infectious disease, and other disease states.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Aethlon Medical Inc.’s Item 2.02 8-K filed November 12, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.